Zecicare-CR Tablet contains Aceclofenac 200mg, a non-steroidal anti-inflammatory drug (NSAID) indicated for the management of pain and inflammation associated with musculoskeletal disorders such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. Aceclofenac exerts its therapeutic effects by selectively inhibiting cyclooxygenase (COX), thereby reducing the synthesis of prostaglandins which are mediators of inflammation, pain, and fever. Zecicare-CR is formulated as a controlled-release tablet to provide sustained drug plasma levels, enhancing patient compliance by reducing dosing frequency. It is effective in alleviating symptoms such as joint pain, swelling, and stiffness, improving overall joint function and quality of life. The medication should be used with caution in patients with a history of gastrointestinal ulcers, bleeding disorders, or renal impairment, and it is contraindicated in individuals with known hypersensitivity to aceclofenac or other NSAIDs. Common adverse effects may include gastrointestinal discomfort, nausea, dizziness, and rash. It is recommended to administer Zecicare-CR with food to minimize gastrointestinal irritation. Patients should adhere to prescribed dosages and consult healthcare professionals before use, especially if pregnant, breastfeeding, or concurrently using other medications to avoid potential drug interactions.